Empirico
Focus: Empirico is a genetics-based drug discovery company focused on rare diseases, headquartered in San Diego. The company operates as a pre-revenue or early-stage biotech with limited public visibility.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Empirico?
AI assessmentEmpirico is a high-risk, early-stage genetics play suitable only for scientists/engineers willing to bet on platform science with no near-term clinical catalysts or revenue proof-of-concept.
Why Work Here
- Genetics-based drug discovery platform offers exposure to cutting-edge precision medicine approaches in a growing field
- Focus on rare diseases positions the company in high-impact, less-competitive therapeutic areas with strong regulatory incentives (orphan drug designation)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Empirico
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.